🔎 Trials Near Me

Utama › Kanser Rahim › California

Kajian klinikal Kanser Rahim di California

9 kajian untuk Kanser Rahim sedang mencari peserta di lokasi di California.

Bandar di California

Teks kajian rasmi (Bahasa Inggeris)

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
Mengambil pesertaFasa 4
Umur 18 ke atas · Wanita · Dikemas kini 25 Sep 2026 · NCT06952660

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

  • Research Site, Duarte
  • Research Site, Irvine
  • Research Site, La Jolla
Mengambil pesertaFasa 3
Umur 18 ke atas · Wanita · Dikemas kini 3 Sep 2026 · NCT06989112

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

  • City of Hope Medical Center, Duarte
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT04329494

Investigations of Reproductive Cancers in Women

  • Sutter Health, San Carlos
Mengambil pesertaKajian pemerhatian
Umur 45 hingga 100 · Wanita · Dikemas kini 17 Ogo 2026 · NCT06527157

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

  • University of California Los Angeles Medical Center, Los Angeles
  • University of California, San Diego; Moores Cancer Center, San Diego
  • USOR Sansum Clinic, Santa Barbara
  • dan 1 lagi
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Ogo 2026 · NCT05579366

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

  • Research Site, La Jolla
  • Research Site, Orange
Mengambil pesertaFasa 3
Umur 18 ke atas · Wanita · Dikemas kini 29 Jul 2026 · NCT07044336

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • Precision NextGen Oncology & Research Center, Beverly Hills
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
  • University of California Los Angeles Rheumatology, Westwood, Los Angeles
Mengambil pesertaFasa 2
Umur 8 ke atas · Semua jantina · Dikemas kini 27 Jul 2026 · NCT05503797

Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer

  • University of California, San Francisco, San Francisco
Mengambil pesertaFasa 1
Umur 18 ke atas · Wanita · Dikemas kini 11 Dis 2025 · NCT06795009

Molecular and Cellular Profiling of Uterine Lavage Collected During Gynecologic Surgery

  • Stanford University, Palo Alto
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Nov 2025 · NCT07044505

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.